Picture of Aker Biomarine ASA logo

AKBM Aker Biomarine ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapMomentum Trap

Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln

April 30 (Reuters) - Aker Biomarine ASA AKBM.OL:

AKER BIOMARINE Q1 ADJUSTED EBITDA USD 12.5 MILLION

AKER BIOMARINE Q1 REVENUE USD 57.3 MILLION

FOLLOWING RECENT INTEREST IN HUMAN HEALTH INGREDIENT BUSINESS UNIT, CO IS EXPLORING ALTERNATIVES, WORKING TOWARDS TRANSACTION IN 2026

Source text: ID:nObi1byVka

Further company coverage: AKBM.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Aker Biomarine ASA

See all news